Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Association Between Hurley Stage and Comorbidities in Hidradenitis Suppurativa.
Journal: International journal of dermatology
Published: September 25, 2025
The impact of GLP-1 receptor agonists on clinical outcomes and healthcare utilization in hidradenitis suppurativa patients: A retrospective cohort study using TriNetX.
Journal: Journal of the American Academy of Dermatology
Published: March 27, 2025
Patient Experiences of Bullous Pemphigoid: Symptoms and Health-Related Quality of Life Impacts.
Journal: Dermatology and therapy
Published: February 25, 2025
Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.
Journal: Dermatology and therapy
Published: January 17, 2025
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Journal: JAMA dermatology
Published: November 27, 2024
The association between obesity and efficacy of psoriasis therapies: An expert consensus panel.
Journal: Journal of the American Academy of Dermatology
Published: October 08, 2024
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.
Journal: Dermatology and therapy
Published: August 16, 2024
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.
Journal: The Journal of dermatological treatment
Published: June 30, 2024
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.
Journal: Journal of the American Academy of Dermatology
Published: February 08, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
Journal: Dermatology and therapy
Published: November 06, 2023
Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2.
Journal: Dermatology and therapy
Published: May 17, 2023
Paraneoplastic pemphigus in a patient with a locally invasive, unresectable type B2 thymoma complicated by an intestinal perforation.
Journal: JAAD case reports
Published: May 03, 2023
Last Updated: 09/26/2026